KNOWLEDGE BASE
Clinical protocols, billing guides, IFUs, and regulatory documentation for every Ventana product. All materials are for healthcare provider use.
Complete IFU for chairside whole blood clot preparation. Covers collection protocol, application technique, and contraindications.
Medicare National Coverage Determination 270.3 — blood-derived products for chronic non-healing wounds. 20-week coverage for diabetic wounds.
Triple-layer dHAICM allograft application protocol. Includes wound bed preparation, sizing guide, and tissue tracking sticker requirements.
Synthetic antimicrobial matrix application guide. Covers wound geometry conformance, ionic silver mechanism, and dressing change intervals.
Low-frequency ultrasound saline-mist debridement protocol. Includes treatment parameters, session frequency, and biofilm disruption endpoints.
Porcine SIS extracellular matrix application protocol. Includes caramelization warning, heat source precautions, and rehydration steps.
Type-I bovine collagen foundation dressing protocol. Covers granulation tissue support, sizing selection, and multi-layer application.
Omega fatty-acid collagen matrix for refractory wounds. Includes vial preparation, 16-unit billing structure, and refractory wound criteria.
Complete HCPCS and CPT code mapping for all Ventana products. Includes Q4316, Q4102, A2005, A2014, G0465/G0460, A6021/A6023, and CPT 97610.
Regional MAC policies for skin substitute reimbursement. Covers Novitas, CGS, Palmetto, WPS, NGS, and First Coast MAC jurisdictions.
POS 11 (Office), POS 22 (Outpatient Hospital), POS 31/32 (SNF). Reimbursement rate differences and documentation requirements by setting.
Step-by-step guide for attaching the $2,050 per-vial invoice to CMS-1500 Box 19. Most MACs require invoice with claim to avoid rejection.
Preparation (G0465) vs. application (G0460) code distinction. Facility rate $1,829.23 vs. non-facility rate $890.18. Modifier guidance included.
Comprehensive billing guide for Cellular and/or Acellular Matrix Products. Covers Q4316, Q4102, A6021/A6023 with MAC-specific documentation requirements.
Complete walkthrough for submitting an IVR through the Ventana portal. Covers patient ID entry, product selection, modifier notes, and approval workflow.
HIPAA-compliant wound documentation protocol. Covers wound dimensions, depth classification, exudate type, and photographic documentation standards.
HCT/P §361 tissue tracking requirements for AmchoPlast and other allograft products. Includes sticker placement, lot number recording, and audit trail.
Product portfolio overview, IVR submission process, compliance requirements, and territory management for Ventana BioSciences representatives.
Patient Health Information handling requirements for IVR submissions. Covers de-identification, minimum necessary standard, and breach notification.
FDA clearance summaries for Microlyte SAM, Arobella QWTS, Maiden Collagen, and Oasis Wound Matrix. Includes predicate device comparisons.
FDA HCT/P Section 361 compliance requirements for AmchoPlast and allograft products. Covers donor eligibility, processing standards, and labeling.
CMS disclosure requirements: reimbursement is not guaranteed. Providers are responsible for verifying specific MAC policies. Sales Agreement payment terms.
Contact your Ventana representative for product-specific IFUs, clinical studies, or custom billing guides.